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OBJECTIVE: Bilirubin is considered an important antioxidant, anti-inflammatory factor and immunomodulator.
The current investigation aimed to explore the association between bilirubin and white blood cell (WBC) count
in a large Chinese cohort.
METHODS: A total of 61091 participants (29259 males, 31832 females) were recruited from a Chinese tertiary
hospital. Data were sorted by sex, and the association between bilirubin and WBC count was analyzed after
dividing bilirubin levels into quartiles.
RESULTS: Most parameters (including age, body mass index, systolic blood pressure, diastolic blood pressure,
alanine aminotransferase, total bilirubin, blood urea nitrogen, creatinine, uric acid, triglycerides and WBC
count) were significantly higher in men than in women. Bilirubin displayed significant negative relationships
with most other measured variables. Linear logistic regression analysis further indicated their negative rela-
tionships. Females showed a significantly higher frequency of leucopenia than males. Significant associations of
leucopenia with high bilirubin quartiles were shown in binary logistic regression models for both sexes, with a
much closer association in men than in women. For instance, for men with bilirubin levels in quartile 4, the
adjusted likelihood of leucopenia was 1.600-times higher than that of men with values in quartile 1. For women
with bilirubin levels in quartile 4, the adjusted likelihood of leucopenia was 1.135-times higher than that of
women with values in quartile 1.
CONCLUSION: Bilirubin is negatively related to WBC count. Significant associations exist between leucopenia
and high bilirubin quartiles, and these associations are more obvious in men than in women.
KEYWORDS: Bilirubin; White Blood Cell (WBC); Sex.
’ INTRODUCTION
Bilirubin is generally considered to be an end-stage pro-
duct of heme metabolism. However, it has now been
suggested to possess a number of crucial properties for the
human body. For instance, it is a potent antioxidant as well
as an anti-inflammatory factor that is capable of scavenging
various reactive oxygen species and free radicals (1,2), as
well as counteracting oxidative stress (3,4). Many epidemio-
logical studies have observed an inverse relationship between
bilirubin and a number of pathological abnormalities, such as
cardiovascular diseases (5), metabolic syndrome (6), dyslipi-
demia (7), and diabetes (8,9). However, we retrieved only two
previous investigations studying the association between
bilirubin and white blood cell (WBC) count, and there was
some discordance (10,11). Tsai et al. (10) analyzed 2458
apparently healthy adults in Taiwan and found that a higher
level of serum total bilirubin (TB) was associated with a lower
WBC count, regardless of other classic cardiovascular risk
factors. In the second paper, which was from Australia,
Badrick et al. (11) analyzed two groups of individuals. After
the removal of patients with an elevated WBC count and TB
level, the community-living patients showed a negative
correlation between the two, but the intensive care unit
patients showed no significant relationship. In this study,
we intended to systematically evaluate the relationship
between TB level and WBC count in a large cohort of Chinese




A cross-sectional, community-based health check-up inve-
stigation was conducted in our hospital with the colla-
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(recruitment was initiated in July 2007), the method of which
was reported previously (12-25). Briefly, a questionnaire was
sent to all the self-reported ostensibly healthy participants
to complete. A blood sample was subsequently obtained
for each person. To limit confounding factors, the following
exclusion criteria were implemented: participants with
histories of hematological, hepatic, renal, gastrointestinal,
inflammatory, infectious, thyroidal, oncological or immu-
nological diseases; subjects taking any medicine that might
influence WBC count, TB, inflammation, infection or the
immune system; WBC count not within the laboratory
calibration reference range; a high level of TB (440 mmol/L
or 2.34 mg/dL); a high level of alanine aminotransferase
(ALT) (4100 U/L); excessive alcohol consumption; and
pregnancy. To fulfill the purpose of this particular investi-
gation, we collected and compiled data during the period
from September 2010 to September 2015. A total of 61091
eligible subjects (29259 males, 31832 females) with adequate
data for analysis were included.
Ethics
The ethical, methodological and protocol aspects of this
study were approved by the institutional review board and
ethics committee of Tianjin Medical University General
Hospital. We confirmed that all methods in the current
study were conducted in compliance with the relevant
guidelines and regulations. Written consent was provided
by all participants in this research.
Measurements
Fasting blood tests and anthropometric measurements
of all participants were conducted during their visits to our
institution. Measurements of body height (BH) in centi-
meters, body weight (BW) in kilograms, and body mass
index (BMI) by dividing BW (kilograms) by the square of BH
(meters2) were performed. The determination of systolic
blood pressure (SBP) and diastolic blood pressure (DBP) was
performed by using a sphygmomanometer. Biochemical
indicators included ALT, TB, blood urea nitrogen (BUN),
creatinine (Cr), uric acid (UA), total cholesterol (TC), trigly-
cerides (TGs), and fasting glucose (FG), which were deter-
mined by an autoanalyzer (Hitachi Corporation, Tokyo,
Japan). WBC count was measured on a hemocytometer
analyzer (Sysmex Corporation, Kobe, Japan).
The laboratory calibration references for the parameters
were as follows: ALT 5-40 U/L, TB 3.4-20 mmol/L (0.20-1.17
mg/dL), BUN 1.7-8.3 mmol/L, Cr 44-115 mmol/L, TC 3.59-
5.18 mmol/L, TGs 0.57-1.70 mmol/L, FG 3.6-5.8 mmol/L,
and WBC count 4.0-9.5 109/L.
Statistics
Data from men and women were analyzed separately.
First, an independent sample’s t test was performed to
measure differences in the indices. Pearson bivariate correla-
tions were analyzed among TB and other parameters. Linear
logistic regression analysis was performed to assess the
independent relationship between WBC count and TB.
Adjustments were performed for possible confounding
factors, including age, BMI, SBP, DBP, TC, TGs and FG.
Then, the TB concentration was divided into quartiles. The
intergroup frequency differences in leucopenia were exam-
ined by the chi-square test. Crude and adjusted odds ratios
(ORs) for leucopenia with 95% confidence intervals (CIs)
were analyzed using binary logistic regression models. We
conducted the statistical analyses with Statistical Package for
Social Sciences software (SPSS version 17.0, Chicago, IL, USA).
Significance was indicated by a p-value less than 0.05.
’ RESULTS
Characteristics of the participants according to sex
There were differences among the parameters with respect
to sex (Table 1). Males were older than females. Most of the
parameters, including age, BMI, SBP, DBP, ALT, TB, BUN, Cr,
UA, TGs and WBCs, were significantly higher in males than
in females. The TC concentration was significantly lower in
males than in females.
Correlations between TB and other key variables
TB demonstrated significant negative relationships with
most of the other variables, including age, BMI, BUN, UA,
TC, TGs, FG and WBCs in men, as well as age, BMI, SBP,
DBP, BUN, TC, TGs, FG and WBCs in women (Table 2).
Table 1 - Participant characteristics.
Parameter Males Females T value
Case number 29259 31832
Age (years) 49.10±12.56 47.45±13.06 15.824**
BMI (kg/m2) 25.68±3.18 23.97±3.47 62.901**
SBP (mmHg) 125.57±16.81 121.13±18.24 31.271**
DBP (mmHg) 80.48±11.17 74.70±10.26 66.748**
ALT (U/L) 25.06±13.61 18.41±10.69 67.438**
TB (mmol/L) 13.37±5.32 11.14±4.52 55.943**
BUN (mmol/L) 5.09±1.27 4.41±1.22 67.262**
Cr (mmol/L) 78.73±11.64 59.79±9.58 220.320**
UA (mmol/L) 357.77±74.99 263.93±59.84 171.599**
TC (mmol/L) 5.10±0.94 5.22±1.03 -14.718**
TGs (mmol/L) 1.73±1.31 1.27±0.86 51.581**
FG (mmol/L) 5.35±1.22 5.06±0.93 33.806**
WBCs (109/L) 5.72±1.18 5.38±1.11 37.084**
BMI=body mass index, SBP=systolic blood pressure, DBP=diastolic blood
pressure, ALT=alanine aminotransferase, TB=total bilirubin, BUN=blood
urea nitrogen, Cr=creatinine, UA=uric acid, TC=total cholesterol,
TGs=triglycerides, FG=fasting glucose, WBCs=white blood cells.
**po0.01 (analyzed by the independent sample’s t test).
Table 2 - Pearson bivariate correlations between TB and other

















TB=total bilirubin, BMI=body mass index, SBP=systolic blood pressure,
DBP=diastolic blood pressure, ALT=alanine aminotransferase, BUN=blood
urea nitrogen, Cr=creatinine, UA=uric acid, TC=total cholesterol,
TGs=triglycerides, FG=fasting glucose, WBCs=white blood cells.
*po0.05, **po0.01.
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Relationship between WBC count and TB
determined by logistic regression analyses
Linear logistic regression analyses were conducted, and a
negative relationship between WBC count and TB was deter-
mined by the following equations. For males, WBC count =
4.309 - 0.023TB + 0.001 age + 0.042BMI + 0.004
SBP - 0.002DBP + 0.026TC + 0.084TGs + 0.003
FG. This equation indicated that each unit increase in TB
would cause a 0.023 unit decrease in TB. For females, WBC
count = 4.239 - 0.009TB - 0.015 age + 0.052BMI +
0.006 SBP - 0.003DBP - 0.048TC + 0.191TGs +
0.042 FG. This equation indicated that each unit increase in
TB would cause a 0.009 unit decrease in TB.
Incidence of leucopenia according to TB quartile
TB quartiles were calculated, and the respective frequency
of leucopenia (defined as WBC count o4.00 109/L) was
compared between sexes. Females showed a significantly
higher overall frequency of leucopenia than males. Detailed
incidences by TB quartiles also demonstrated the same
pattern of differences between the sexes, and leucopenia
frequency increased as the TB level increased (Table 3).
Correlations of leucopenia with different TB
quartiles according to sex
Binary logistic regression models were adopted to calcu-
late the associations of leucopenia with different TB quartiles
according to sex, using the lowest TB quartile as a reference
(Table 4). Significant associations were demonstrated for
leucopenia in the high TB quartiles for both sexes, with
significantly closer associations in men than in women. The
adjusted risks included age, BMI, SBP, DBP, TC, TGs and FG
as covariates. Significant ORs were maintained for leucope-
nia in all high TB quartiles in males, while the associations
with the third and fourth TB quartiles were maintained in
females. For instance, for men with TB levels in quartile 4,
the adjusted likelihood of leucopenia was 1.600-times higher
than that of men with TB levels in quartile 1. For women
with TB levels in quartile 4, the adjusted likelihood of
leucopenia was 1.135-times higher than that of women with
TB levels in quartile 1.
’ DISCUSSION
In mammals, due to the activities of the heme oxygenase
and biliverdin reductase enzymes, bilirubin is produced
during the physiological breakdown of heme. Bilirubin is not
water soluble and requires a series of metabolic reactions for
its further excretion, beginning with its binding to albumin.
For decades, bilirubin has been viewed as an excretory
product and a potentially toxic metabolite of heme metabo-
lism that does not exert physiological benefits in humans.
In particular, hyperbilirubinemia is generally viewed as a
negative phenomenon because infants with jaundice are
associated with kernicterus, and adults with jaundice are the
harbingers of hepatic failure. However, over the span of
human evolution, the production pathway of bilirubin has
been consistently conserved. The teleological supposition is
that bilirubin plays unique roles with physiological impor-
tance (26). In fact, bilirubin has been discovered to possess
Table 4 - The risks of leucopenia according to TB quartiles in different sex.
TB Quartile Males Females
TB values Crude OR (CI)# Adjusted OR (CI)ˆ TB values Crude OR (CI)# Adjusted OR (CI)ˆ
TB Quartile 1 TB o9.60 (mmol/L, reference) TB o8.00 (mmol/L, reference)
TB Quartile 2 9.60 p TB o12.50 1.341 (1.122-1.603)** 1.285 (1.074-1.537)** 8.00 p TB o10.30 1.150 (1.022-1.294)* 1.088 (0.965-1.226)
TB Quartile 3 12.50 p TB o16.10 1.557 (1.308-1.853)** 1.467 (1.231-1.748)** 10.30 p TB o13.40 1.245 (1.109-1.398)** 1.137 (1.011-1.279)*
TB Quartile 4 TB X16.10 1.799 (1.519-2.131)** 1.600 (1.349-1.898)** TB X13.40 1.280 (1.139-1.437)** 1.135 (1.009-1. 277)*
TB=total bilirubin, OR=odds ratio, CI=confidence interval.
#Logistic regression model using TB Quartile 1 as a reference, including no covariate.
Lˆogistic regression model using TB Quartile 1 as a reference, including age, body mass index, blood pressure, total cholesterol, triglycerides and fasting
glucose ascovariates.
*po0.05, **po0.01.
Table 3 - Incidence of leucopenia in different sex by TB quartiles.
Incidence (number of patients) in different quartiles
Quartile 1 Quartile 2 Quartile 3 Quartile 4 Total
Male
Mean±SD ( 109/L) 5.94±1.22 5.74±1.17 5.65±1.17 5.54±1.12 5.72±1.18
Leucopenia# 2.971% (220) 3.945% (291) 4.550% (326) 5.223% (382) 4.166% (1219)
Normal WBC# 97.029% (7184) 96.055% (7085) 95.450% (6839) 94.777% (6932) 95.834% (28040)
Female
Mean±SD ( 109/L) 5.49±1.15 5.38±1.10 5.34±1.10 5.29±1.08 5.38±1.11
Leucopenia# 6.968% (565) 7.930% (626) 8.529% (682) 8.745% (685) 8.036% (2558)
Normal WBC# 93.032% (7544) 92.070% (7268) 91.471% (7314) 91.255% (7148) 91.964% (29274)
Chi-square value
Leucopenia comparison# 128.650** 107.267** 96.413** 71.659** 393.593**
TB=total bilirubin, WBC=white blood cell, SD=standard deviation.
#Leucopenia was defined as a WBC count o4.00 109/L.
Cˆomparing the incidence of leucopenia between males and females by the chi-square method.
**po0.01.
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beneficial effects for the human body at physiologic concen-
trations. For instance, bilirubin has demonstrated an aston-
ishing potency to scavenge overproduced free radicals and
can also exert anti-inflammatory functions and powerful
immunosuppressive effects. In addition, it can produce direct
effects upon cell signaling (1-4). For example, bilirubin has
been proven to be more effective at protecting lipids from
oxidation than other water-soluble antioxidants, such as
glutathione (27). Serum bilirubin has also been demonstrated
to be a major contributor to the total antioxidant capacity in
blood plasma (28).
Systemic inflammation and oxidative stress are important
mechanisms in the development of various metabolic abnor-
malities (4). The powerful antioxidant and anti-inflammatory
capacities of bilirubin are reported to be the basis for
protection against diseases such as cardiovascular diseases
(5) and metabolic syndrome (6). In addition, the anti-
inflammatory effect of bilirubin has been demonstrated in
its protective role against rheumatoid arthritis (29) and colitis
(28). Bilirubin has also been shown to be an immunomodu-
lator, which makes bilirubin helpful in the treatment of
diseases such as multiple sclerosis (30), lupus erythematosus
(31), and autoimmune encephalomyelitis (32). Several mole-
cular pathways have been identified to explain the above
mechanisms, for example, the nuclear factor kappa B (NK-kB)
pathway (33) and the extracellular signal-regulated kinase 1/2
(ERK1/2) pathway (34,35).
Only two previous investigations have studied the
relationship between TB and WBC count (10,11); the results
in the study by Tsai et al. (10) were generally in agreement
with our research. The advantages of the current study
included the large number of participants and the compre-
hensive and robust statistical analyses plus an emphasis on
sex differences. In our opinion, the probable mechanism for
the negative relationship between TB and WBC count could
be protean and complicated (10). First, negative correlations
between TB and inflammatory markers are reported to exist,
which could regulate WBC production (36). Second, an
elevated WBC count could reflect enhanced cellular oxida-
tive stress, which could lead to the consumption and even
depletion of natural antioxidants, thus leading to a decrease
in TB concentration (10). Third, metabolic abnormalities,
such as metabolic syndrome, may be an important under-
lying link in the association between TB and WBC count. It is
reported that people with an increased level of WBCs will
have an elevated risk of metabolic syndrome development,
which is possibly due to chronic inflammation (19). How-
ever, epidemiologic surveys have reported that TB was
negatively correlated with a number of abnormalities, such
as cardiovascular diseases (5) and metabolic syndrome (6).
The proposed reason for this phenomenon is a regulatory
effect derived from insulin resistance, which is the core
proposed mechanism in metabolic syndrome pathogenesis
(37). Finally, inflammatory responses could be suppressed by
bilirubin due to its preventive effects on the migration of
leukocytes into target tissues, which may be mediated by a
disruption in vascular cell adhesion molecule-1-dependent
cell signaling. Therefore, for example, bilirubin can prevent
dextran sodium sulfate-induced colitis by inhibiting leuko-
cyte migration across the vascular endothelium and by
suppressing inducible nitric oxide synthase expression (38).
There are several limitations to our study. First, this study
was cross-sectional, which does not allow for conclusions
regarding causal relationships. Prospective and interventional
investigations should be planned in the future. Second, we did
not measure markers of inflammation in our population
because of the budget shortage. Third, we measured blood
parameters in only a single blood sample, and we did not
confirm the results due to the budget shortage, which may
have resulted in less-precise results than those obtained from
repeated measurements. Fourth, serum TB may be influenced
by a number of hereditary factors (39) or dietary habits (40),
which were not fully analyzed in the current study. Finally,
a number of the participants with various undetected con-
founding factors might not be aware of their medical
conditions, which could influence our results.
’ CONCLUSIONS
In conclusion, TB is inversely related to WBC count.
High TB quartiles are associated with significant risks for
leucopenia, and this risk was more obvious in men than
in women. It seems reasonable to suggest the assessment
of WBC count when abnormal TB levels are found. The
exact reason behind this association still requires further
investigation.
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